Mebendazole Augments Sensitivity to Sorafenib by Targeting MAPK and BCL-2 Signalling in N-Nitrosodiethylamine-Induced Murine Hepatocellular Carcinoma

Scientific Reports- United Kingdom

doi 10.1038/s41598-019-55666-x

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

MicroRNA‑223 Promotes Hepatocellular Carcinoma Cell Resistance to Sorafenib by Targeting FBW7

Oncology Reports
MedicineCancer ResearchOncology
2018English

Neuropilin-2 Induced by Transforming Growth Factor-Β Augments Migration of Hepatocellular Carcinoma Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

Preventive Effects of Combinative Natural Foods Produced by Elite Crop Varieties Rich in Anticancer Effects on N -Nitrosodiethylamine-Induced Hepatocellular Carcinoma in Rats

Food Science and Nutrition
Food Science
2018English

Hedgehog Signalling Mediates Drug Resistance Through Targeting TAP1 in Hepatocellular Carcinoma

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2020English

Extent of DNA 2-Hydroxyethylation by N-Nitrosomethylethylamine and N-Nitrosodiethylamine in Vivo

Carcinogenesis
MedicineCancer Research
1986English

Successful Treatment of Hepatocellular Carcinoma With Regorafenib After Sorafenib-Induced Hypersensitivity

Internal Medicine
Internal MedicineMedicine
2019English

A Complete Response Induced by 21-Day Sorafenib Therapy in a Patient With Advanced Hepatocellular Carcinoma

Internal Medicine
Internal MedicineMedicine
2013English

Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma

Journal of Liver Research, Disorders & Therapy
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy